VEGFA and adenomyosis: Notably, recent experimental data also support the potential therapeutic relevance of angiogenesis suppression in adenomyosis, as pharmacologic inhibition of VEGF signaling reduced lesion severity in vivo [26], aligning with the molecular trends observed in our study.